Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Volume: 380, Issue: 7, Pages: 617 - 628
Published: Feb 14, 2019
Abstract
Background Patients who have residual invasive breast cancer after receiving neoadjuvant chemotherapy plus human epidermal growth factor receptor 2 (HER2)–targeted therapy have a worse...
Paper Details
Title
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Published Date
Feb 14, 2019
Volume
380
Issue
7
Pages
617 - 628
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.